ADAMTS13 and thrombotic thrombocytopenic purpura: Zheng et al. [10] reported a severe deficiency of ADAMTS13 in 80% of patients with TTP and in none of those with autoimmune-, transplantation-, malignancy-, medication-, or pregnancy-associated (secondary forms) of TTP.